Status:
COMPLETED
Eradication of Malignant Carcinoma in the Breast Tissue
Lead Sponsor:
Optimal Health Research
Conditions:
Breast Cancer
Eligibility:
FEMALE
35-75 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to confirm the findings of an early study and expand our knowledge of treating Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor.
Eligibility Criteria
Inclusion
- Clinical diagnosis of breast cancer
- Referred to the study by their treating physician
Exclusion
- Any type of treatment for breast cancer before starting the study
Key Trial Info
Start Date :
February 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02286778
Start Date
February 1 2016
End Date
August 1 2017
Last Update
August 3 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.